Just days ahead of his big strategic reveal, Sanofi CEO Paul Hudson lines up a $350M sale
We won’t find out exactly what Paul Hudson wants to focus on in building the future at Sanofi for another 8 days, when he’s promised the big reveal. But chances are whatever he plans to concentrate on, it won’t be the surgical products group at Seprafilm.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 77,000+ biopharma pros reading Endpoints daily — and it's free.